Literature DB >> 19692289

Advances in imaging in the work-up of head and neck cancer patients.

Remco de Bree1, Jonas A Castelijns, Otto S Hoekstra, C René Leemans.   

Abstract

Accurate staging at the time of the diagnosis of head and neck squamous cell carcinoma (HNSCC) is critical for selection of the appropriate treatment strategy. Therefore, optimizing pre-treatment imaging in the diagnostic work-up is of great importance. CT and MRI are the corner stones of diagnostic work-up. Technical improvements will increase the value of these techniques even further. PET and PET-CT became a standard imaging techniques for HNSCC patients. It may be helpful for the detection of occult primary tumours, but its sensitivity for the detection of occult lymph node metastases is too low. Alternatively, the sentinel node procedure may be sufficiently accurate to avoid elective treatment of the neck. Screening for distant metastases should be performed only in HNSCC patients with high risk factors by FDG-PET-CT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692289     DOI: 10.1016/j.oraloncology.2009.07.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

Review 1.  PET imaging biomarkers in head and neck cancer.

Authors:  Sarah Differding; François-Xavier Hanin; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

2.  Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma.

Authors:  Yukako Ichimiya; Krishna Alluri; Charles Marcus; Simon Best; Christine H Chung; Rathan M Subramaniam
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

Review 3.  Imaging in oncology--over a century of advances.

Authors:  Bhuey Sharma; Axel Martin; Susannah Stanway; Stephen R D Johnston; Anastasia Constantinidou
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

4.  Diffusion-weighted imaging of the head and neck in healthy subjects: reproducibility of ADC values in different MRI systems and repeat sessions.

Authors:  A S Kolff-Gart; P J W Pouwels; D P Noij; R Ljumanovic; V Vandecaveye; F de Keyzer; R de Bree; P de Graaf; D L Knol; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-25       Impact factor: 3.825

5.  Comparing primary tumors and metastatic nodes in head and neck cancer using intravoxel incoherent motion imaging: a preliminary experience.

Authors:  Yonggang Lu; Jacobus F A Jansen; Hilda E Stambuk; Gaorav Gupta; Nancy Lee; Mithat Gonen; Andre Moreira; Yousef Mazaheri; Snehal G Patel; Joseph O Deasy; Jatin P Shah; Amita Shukla-Dave
Journal:  J Comput Assist Tomogr       Date:  2013 May-Jun       Impact factor: 1.826

6.  Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [18F]FDG PET/CT and MRI.

Authors:  Christian Linz; Roman C Brands; Olivia Kertels; Alexander Dierks; Joachim Brumberg; Elena Gerhard-Hartmann; Stefan Hartmann; Andreas Schirbel; Sebastian Serfling; Yingjun Zhi; Andreas K Buck; Alexander Kübler; Julian Hohm; Constantin Lapa; Malte Kircher
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-29       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.